BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381 AND Treatment
7 results:

  • 1. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
    Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
    Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of cardiac toxicity of systemic treatments in Moroccan patients followed for localized breast cancer: Prospective observational study of 549 cases.
    Haffadi M; Tawfiq N; Dakir M; Boughafour M; Bouchbika Z; Benchakroun N; Jouhadi H; Sahraoui S; Benider A; Krikez I; Benmallek R; Habbal R
    Gulf J Oncolog; 2021 Jan; 1(35):59-65. PubMed ID: 33716214
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.
    Kurmasheva RT; Bandyopadhyay A; Favours E; Del Pozo V; Ghilu S; Phelps DA; Erickson SW; Peer CJ; Figg WD; Smith MA; Houghton PJ
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27820. PubMed ID: 31099166
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.
    Martínez P; Galve E; Arrazubi V; Sala MÁ; Fernández S; Pérez CE; Arango JF; Torre I
    Reumatol Clin (Engl Ed); 2019; 15(4):211-217. PubMed ID: 29032291
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Epigenetic Landscape of Promoter Genome-wide Analysis in breast cancer.
    Karsli-Ceppioglu S; Dagdemir A; Judes G; Lebert A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Sci Rep; 2017 Jul; 7(1):6597. PubMed ID: 28747748
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
    Oesch S; Walter D; Wachtel M; Pretre K; Salazar M; Guzmán M; Velasco G; Schäfer BW
    Mol Cancer Ther; 2009 Jul; 8(7):1838-45. PubMed ID: 19509271
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.